Live Webinar: Patient Selection for Oral Appliance Therapy (OAT) for Sleep-disordered Breathing

Wednesday, November 18, 2026

1:00 PM ET/12:00 PM CT/11:00 AM MT/10:00 AM PT

Expected Duration and CE Credit(s): Up to 1.0 hour

Presented By: Olivier Vanderveken, MD, PhD

Moderated By: Richard Dunn, DDS

This webinar will not be recorded.

Jointly Provided By: This activity is jointly provided by the American Board of Dental Sleep Medicine (ABDSM) and the American Academy of Dental Sleep Medicine (AADSM) as the ADA CERP Recognized Provider.

Register

Registration is available for ABDSM Diplomates only, regardless of membership status with the AADSM. There is no fee to register.

This webinar will discuss the tools available in clinical practice to aim at selecting the right treatment for the right patient. For oral appliance therapy (OAT) in particular, there is the need for more predictable, and personalized approaches and to move away from ’trial-and-error’.

This webinar will focus on the role of anthropometrics, clinical and dental parameters, drug-induced sleep endoscopy (DISE) and polysomnographic pheno-endotyping bringing a thorough understanding of the method of a more precise and personalized prediction of OAT outcomes in a prospective way for individual patients. 

Olivier Vanderveken, MD, PhD

Target Audience: ABDSM Diplomates interested in using precision medicine approaches, including DISE, phenotyping, and clinical predictors, to optimize patient selection and improve oral appliance therapy outcomes for sleep-disordered breathing. 

Objectives

At the conclusion of this webinar, participants will be able to:

1. Understand the role of anthropometrics that includes the basis findings of the dental and clinical examination, and the results of a recent sleep study, in the prediction of treatment outcomes of OAT for SDB.
2. Identify the specific findings during a drug-induced sleep endoscopy (DISE) that are associated with a better or worse outcome of OAT for SDB - in addition, the DISE profiles that are associated with the outcome of other SDB therapies such as hypoglossal nerve stimulation therapy and other sleep surgeries will be discussed; and
3. Summarize the most important aspects regarding the SDB pheno-endotypes that can be derived from a sleep study in a non-invasive way, and their role in the pro-active prediction of OAT treatment outcomes.

Speaker Bio

Olivier Vanderveken, MD, PhD, is an ENT, Head and Neck Surgeon at the Antwerp University Hospital in Belgium where he is appointed as the Chair of the Department. He holds a position as full professor at the Faculty of Medicine and Health Sciences of the University of Antwerp. He is also serving as the Vice-Dean at the level of this Faculty. Currently he also is Chair of ENT at UZ Brussels and full professor at VUB in Brussels. At the Faculty of Medicine & Dentistry of University of Alberta, Dr. Olivier Vanderveken holds an appointment as Adjunct Assistant Professor.

Prof. Dr. Vanderveken received his medical degree from University of Antwerp in 2001. He completed his residency at the Antwerp University Hospitals. In 2007, he obtained a PhD in Medical Sciences. His main research projects are in the area of sleep-disordered breathing (SDB) on the topic of the fundamental and multidisciplinary approach to upper airway collapse during SDB. His research focuses in particular on pathophysiological assessment of upper airway collapse including endo/phenotyping, drug-induced sleep endoscopy, treatment of obstructive sleep apnea with mandibular advancement devices and upper airway surgery including hypoglossal nerve stimulation and transoral robotic surgery.

Prof. Dr. Vanderveken is the Editor-in-Chief of the journal ‘B-ENT’, the official publication of the Royal Belgian Society of ENT and the Deputy Editor of the AADSM Journal of Dental Sleep Medicine. He has co-authored several professional scientific publications in high-impact peer reviewed journals.